Table 3. Distribution of microsatellite complexes (MCs) from patients according to HIV status.
| MCs | HIV positiven (%) | HIV negativen (%) | Unknown statusn (%) | Total number of isolatesn (%) |
| MC1 | 6 (2.5) | 6 (3.9) | 2 (5.9) | 14 (3.3) |
| MC2 | 30 (12.7) | 104 (66.6) | 6 (17.7) | 140 (32.9) |
| MC3 | 33 (14) | 8 (5.1) | 1 (2.9) | 42 (9.9) |
| MC8 | 138 (58.5) | 4 (2.6) | 19 (55.9) | 161 (37.8) |
| MC12 | 2 (0.9) | 8 (5.1) | 0 | 10 (2.3) |
| MC15 | 5 (2.1) | 6 (3.9) | 0 | 11 (2.6) |
| MC16 | 1 (0.4) | 13 (8.3) | 3 (8.8) | 17 (4) |
| MC17 | 12 (5.1) | 1 (0.6) | 1 (2.9) | 14 (3.3) |
| None MCs | 9 (3.8) | 6 (3.9) | 2 (5.9) | 17 (4) |
| Total | 236 | 156 | 34 | 426 |
The predominant MC in each HIV status category is indicated in bold.